<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267749/" ref="ordinalpos=1278&amp;ncbi_uid=6967784&amp;link_uid=PMC4267749" image-link="/pmc/articles/PMC4267749/figure/Fig1/" class="imagepopup">Figure 1.  From: Notch <span class="highlight" style="background-color:">signaling</span> and EMT in non-small cell lung cancer: biological significance and therapeutic application. </a></div><br /><div class="p4l_captionBody"> <b>The signaling pathways in lung cancer.</b> Oncogene activation or loss of tumor suppressor initiates lung tumor formation. The Notch, Wnt and TGF-Î² signaling pathway are involved in the induction of EMT, CSCs and metastasis of NSCLC.</div></div>